Objective:本研究主要探討Cataflam和Ultracet藥物介入是否降低腕隧道症候群( Carpal tunnel syndrome )、橈突莖肌腱炎( De Quervain’s tenosynovitis )和板機指( Trigger finger )術後疼痛的相關研究。 Methods:本研究是類實驗型研究設計( Quasi-Experimental Study ),其研究方法:(1)調閱腕隧道症候群、橈突莖肌腱炎和板機指術後患者之病歷;(2)患者術後使用消炎( Cataflam )或止痛藥物( Ultracet )來降低疼痛者之病歷紀錄;(3)患者術後一星期內回診,自述每天疼痛分數者。研究納入之有效樣本數總共有:腕隧道症候群樣本數107人、橈突莖肌腱炎樣本數39人和板機指樣本數249人。 Results:我們的研究結果發現Cataflam藥物介入降低板機指術後疼痛指數( p = 0.001 )。橈突莖肌腱炎和腕隧道症候群術後疼痛指數在兩者藥物介入是沒有統計上的顯著(p > 0.05)。 Conclusion:我們的研究發現,板機指患者術後藥物的介入,Cataflam降低疼痛的效果優於Ultracet。
Objective: The aim of this study was to investigate whether Cataflam and Ultracet treatment improve postoperative pain of carpal tunnel syndrome, De Quervain's tenosynovitis and trigger finger. Methods: This study was a retrospective quasi-experimental study. Three study procedures were used: (1) The medical charts of these postoperative patients were reviewed. (2) The medical record of using Cataflam or Ultracet for postoperative pain management were collected. (3) The postoperative pain scores were recorded within one week after surgery. We recruited 107 carpal tunnel syndrome, 39 De Quervain’s tenosynovitis, and 249 trigger finger patients involved in the analysis. Results: We found that Cataflam reduced the postoperative pain scores of trigger finger ( p = 0.001 ), while not significantly improved the postoperative pain scores of De Quervain’s tenosynovitis and carpal tunnel syndrome ( p > 0.05 ). Conclusion: Cataflam may be a better treatment than Ultracet to improve postoperative pain in trigger finger patients.